Mineral content of raw materials. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

Technical parameters of ultrafine cement. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

Technical parameters of PVA fiber. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

Sample preparation and testing flow chart. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

XRD patterns of MUCG at different curing age. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

Results of significance for regression factors. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

FTIR spectra of MUCG at different curing age. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

Description of fitting models. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

Mineral composition of UFC, B, and SF. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

Significant condition. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. …”

Dynamics of cortical actin levels in protrusion membrane during <i>S</i>. <i>flexneri</i> cell-to-cell spread. by Volkan K. Köseoğlu (12055346)

Expression of p-STAT3 in the four groups. by Zheng Cheng (426625)

Expression of NF-κB p65 in the four groups. by Zheng Cheng (426625)

Means and standard deviations for Known condition. by Mengnan Wu (769253)

Correlation between p-STAT3, NF-κB and cytokines (TNF-α and IL-6 by Zheng Cheng (426625)

Degradation Kinetics of Antibiotic Resistance Gene <i>mecA</i> of Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) during Water Disinfection with Chlorine, Ozone, and Ultr... by Yegyun Choi (10039214)

“…Measured rate constants for extra-<i>mecA</i> increased linearly with amplicon length for FAC and O₃, or with number of intrastrand pyrimidine doublets for UV, which enabled prediction of degradation rate constants of extra-<i>mecA</i> amplicons based on sequence length and/or composition. …”

Longitudinal analysis of official fly registered to HPD. by Kathryn P. Hacker (3329439)

“…Fly complaints modeled as a linear harmonic model with decreasing amplitude over time.…”

Table_1_A rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis.xlsx by Paola Maura Tricarico (14213204)

“…Since several transcriptome studies have shown a significantly decreased expression of DCD in HS skin, we hypothesised that the identified frameshift insertion was a loss-of-function mutation that might be associated with HS susceptibility in this family. …”

Factors that Affect Pancreatic Islet Cell Autophagy in Adult Rats: Evaluation of a Calorie-Restricted Diet and a High-Fat Diet by Qianqian Sun (703509)

“…At 16 weeks, the expressions of LC3B, LAMP2 and AP markedly increased in both the HFD (P<0.01) and CRD (P<0.05) groups; however, an increase in the AI (P<0.05), cleaved caspase-3 and Beclin1 expression and a decrease in the expressions of BCL2 and BCLXL (P<0.05) were observed in only the HFD group. …”

Data_Sheet_3_Modulation of Microglial Activation by Adenosine A2a Receptor in Animal Models of Perinatal Brain Injury.pdf by Marina Colella (5735873)

“…Caffeine, a nonspecific antagonist of adenosine receptors (ARs), is widely used to treat apnea of prematurity and has been linked to a decrease in the incidence of cerebral palsy in premature infants. …”